跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Roflexin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Roflexin
Approved
STANDARD
Roflexin
Akriti Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
28c8fe2c2e73c1a7
Company
Akriti Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
28c8fe2c2e73c1a7
Drug Approval Philippines Name
Roflexin
Product Name
Roflexin
Registration Number
DRP-13199-1
Brand Name
Roflexin
Generic Name
Ciprofloxacin (as hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Akriti Pharmaceuticals Pvt. Ltd.
Importer
Aglobal Care, Inc.
Distributor
Reta Drug
Issuance Date
28 May 2023
Expiry Date
27 December 2027
Pharmacologic Category
Antibacterial (Fluoroquinolone)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
28c8fe2c2e73c1a7
Type
Standard
Back to Philippines FDA Approvals